Company: RGBP
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001641172-25-011206
Chunk: 26

Company: Regen BioPharma Inc
Filing Date: 2025-05-16
Form: 10-Q
Item: Part II, Item 2
Chunk 26
---
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds

On
November 1, 2024 the Company paid a dividend to all shareholders of record as of the record date of October 17. 2024 a dividend consisting
of one share of the Company’s common stock for every one share held as of October 17, 2024. 15,426, 385 common shares were paid
to Shareholders of Record.

On
November 4, 2024 the Company issued 500,000 shares of the Company’s common stock in satisfaction of $20,000 of principal convertible
indebtedness.

The
shares were issued pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended (the “ Act”). No underwriters were
retained to serve as placement agents for the sale. The shares were sold directly through our management. No commission or other consideration
was paid in connection with the sale of the shares. There was no advertisement or general solicitation made in connection with this Offer
and Sale of shares. A legend was placed on the certificate that evidences the Shares stating that the Shares have not been registered
under the Act and setting forth or referring to the restrictions on transferability and sale of the shares.

On
November 13, 2024 the Company issued 370,084 shares of the Company’s common stock as consideration for nonemployee services.

The
shares were issued pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended (the “ Act”). No underwriters were
retained to serve as placement agents for the sale. The shares were sold directly through our management. No commission or other consideration
was paid in connection with the sale of the shares. There was no advertisement or general solicitation made in connection with this Offer
and Sale of shares. A legend was placed on the certificate that evidences the shares stating that the shares have not been registered
under the Act and setting forth or referring to the restrictions on transferability and sale of the shares.

Item
6. Exhibit Index